Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313605) titled 'POCUS-Guided Esmolol in Septic Shock: A Pilot RCT' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: John Basmaji
Condition:
Septic Shock
Intervention:
Drug: Esmolol
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: January 15, 2026
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/study/NCT07313605
Published by HT Digital Content Services with permission from Health Daily Digest....